Inflammatory disorders, including obliterative airway disease, renal fibrosis, diabetic nephropathy, and liver fibrosis are treated with immunosuppressive triptolide compounds, in particular triptolide compounds effective to inhibit TGF-β production in a patient afflicted with such a disorder.
炎症性疾病,包括闭塞性气道疾病、肾脏纤维化、糖尿病肾病和肝脏纤维化,可使用
免疫抑制剂三尖杉酯化合物进行治疗,特别是在患有此类疾病的患者中,有效抑制TGF-β生成的三尖杉酯化合物。